As drug makers relentlessly lobby for a blank check to keep overcharging Americans, continued bipartisan action to lower drug prices is critical including common sense reforms to stop drugmakers abuse of the patent system, restore competition, and move toward pricing based on clinical value and not on the lavish tax-deductible marketing campaigns brand drug makers use to drive up consumer demand for high-priced drugs and raise costs for everyone, an AHIP spokesperson said in a statement shared with Healthline.
CrossRef Early HBcrAg and AntiHBc Levels Identify Patients at High Risk for Severe Flares After Nucleos(t)ide Analogue CessationA Pooled Analysis of Two Clinical Trials Edo J
Ensuring proper reconstitution with Bacteriostatic Reconstitution Water (bac) is also essential for injectables
Glucagon-like peptide I improved glycemic control in type I diabetes
What the Evidence Does and Does Not Show Be honest about where the evidence stands
Research shows that approximately 50-70% of weight loss is retained long-term when patients maintain dietary and exercise changes, though individual outcomes vary significantly based on genetics and behavioral consistency
